Tech Company Financing Transactions
Myosin Therapeutics Funding Round
Myosin Therapeutics, operating out of Jupiter, raised $4.5 million from Small Business Innovation Research (SBIR).
Transaction Overview
Company Name
Announced On
8/19/2025
Transaction Type
Venture Equity
Amount
$4,500,000
Round
Undisclosed
Proceeds Purpose
The funding will support Myosin Therapeutic's Phase I STAR-GBM dose escalation and expansion trial of MT-125, a first-in-class novel small molecule therapeutic being evaluated in patients with newly diagnosed, MGMT unmethylated glioblastoma.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
130 Scripps Way
Jupiter, FL 33458
USA
Jupiter, FL 33458
USA
Phone
Undisclosed
Website
Email Address
Overview
Myosin Therapeutics is a privately-held biopharmaceutical company developing novel medications targeting cellular motor proteins, specialized molecular machines that convert energy into mechanical work inside cells. Molecular motors are an under-exploited area of disease treatment, including cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Co-Founder
Theodore Kamenecka
Co-Founder
Courtney Miller
Browse more venture capital transactions:
Prev: 8/19/2025: Firecrawl venture capital transaction
Next: 8/19/2025: Databricks venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs